Physician
May Abdo-Matkiwsky, D.O.
According to 2025 Medicare claims, May Abdo-Matkiwsky, D.O. (NPI: 1306887708) practices hematology/oncology in the Newark, NJ market, with the plurality of this provider's patient population coming from Sussex, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 07871-2625.
Abdo-Matkiwsky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,028 traditional Medicare patients, billed 294,890 HCPCS/CPT codes, and received $5,815,967 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,542 prescription claims across 461 beneficiaries totaling $4,434,007 in drug costs, led by Pomalyst (Pomalidomide). 2023 DME data shows 24 claims. Open Payments data shows 24 records totaling $1,732. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,623,903 to $5,815,967. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $696,212 to $4,434,007. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $8,451 to $5,749.